Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
ZVRA similar filings
- 28 Feb 24 Amendments to Articles of Incorporation or Bylaws
- 5 Feb 24 Financial Statements and Exhibits
- 23 Jan 24 Departure of Directors or Certain Officers
- 8 Jan 24 Zevra Therapeutics Receives FDA Acceptance of Resubmission of NDA for Arimoclomol as a Treatment for Niemann-Pick Disease Type C
- 27 Dec 23 Zevra Therapeutics Announces Resubmission of Arimoclomol New Drug Application to the U.S. Food and Drug Administration
- 20 Nov 23 Zevra Therapeutics Completes Acquisition of Acer Therapeutics in its Journey to Become a Leading Rare Disease Company
- 7 Nov 23 Zevra Therapeutics Reports Corporate Updates and Third Quarter 2023 Financial
Filing view
External links
